$-0.01
(Market cap
$19 Mln
Recently Viewed
Clear AllMarket cap
$19 Mln
Revenue (TTM)
$71 Mln
P/E Ratio
--
P/B Ratio
1
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
-0.9 %
ROCE
-- %
Industry P/E
24.41
EV/EBITDA
-1.6
Debt to Equity
0
Book Value
$--
EPS
$-0.9
Face value
--
Shares outstanding
50,824,657
CFO
$-71.58 Mln
EBITDA
$-7.65 Mln
Net Profit
$-56.40 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Cosmos Health (COSM)
| -24.7 | 15.9 | -25.9 | -11.0 | -52.4 | -69.9 | -44.9 |
|
BSE Sensex
| -8.7 | 2.7 | -5.2 | -2.4 | 8.6 | 9.8 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Cosmos Health (COSM)
| -25.6 | -52.3 | -69.1 | -94.6 | -33.9 | 131.8 | -45.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Cosmos Health (COSM)
|
0.4 | 19.3 | 71.3 | -28.5 | -22.3 | -137 | -- | 1.0 |
| 12.8 | 3,993.9 | 2,323.3 | 44.1 | 12.3 | -- | 56.9 | 105.4 | |
| 0.6 | 23.9 | 4.2 | -3.6 | -55.0 | -0 | -- | 1.2 | |
| 3.1 | 1,118.8 | 839.3 | -57.5 | -2.3 | -7.1 | -- | 1.2 | |
| 8.1 | 5,499.1 | 7,682.7 | 438.7 | 15.9 | 7.5 | 11.7 | 1.1 | |
| 226.6 | 555,224.5 | 96,362.0 | 21,040.0 | 20.2 | 26.2 | 26.7 | 6.8 | |
| 0.1 | 126.5 | 0.0 | -17.4 | -- | -- | -- | 18.1 | |
| 46.4 | 112,077.9 | 47,354.0 | 7,555.0 | 19.6 | 10.3 | 20.2 | 1.3 | |
| 1.0 | 4.9 | 36.0 | -6.9 | -12.9 | -29.4 | -- | 0.2 |
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical... devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois. Read more
Chairman & CEO
Mr. Grigorios Siokas
Chairman & CEO
Mr. Grigorios Siokas
Headquarters
Chicago, IL
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Cosmos Health Inc (COSM) is $0.37 (NASDAQ) as of 27-Apr-2026 10:33 EDT. Cosmos Health Inc (COSM) has given a return of -52.42% in the last 3 years.
Since, TTM earnings of Cosmos Health Inc (COSM) is negative, P/E ratio is not available.
The P/B ratio of Cosmos Health Inc (COSM) is 1.05 times as on 24-Apr-2026, a 81 discount to its peers’ median range of 5.60 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.07
|
1.11
|
|
2024
|
-0.98
|
0.64
|
|
2023
|
-1.21
|
0.62
|
|
2022
|
-3.49
|
1.22
|
|
2021
|
-7.26
|
13.20
|
The 52-week high and low of Cosmos Health Inc (COSM) are Rs 1.32 and Rs 0.28 as of 27-Apr-2026.
Cosmos Health Inc (COSM) has a market capitalisation of $ 19 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Cosmos Health Inc (COSM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.